American Scientific Resources (ASFX)

[makeamint2]

"We have incurred net losses since our inception. We have incurred net
losses applicable to common shareholders of $4,787,637 and $1,935,779
for the nine months ended September 30, 2010 and 2009, respectively,
and $3,424,851 and $6,406,954 for the fiscal years ended December 31,
2009 and 2008, respectively. As of September 30, 2010, we have an
accumulated deficit of $24,819,261 and a shareholders’ deficit of
$4,200,399. We currently have sufficient cash to sustain our
operations for a period of approximately one month. We will require
additional funds through the receipt of conventional sources of
capital or through future sales of our common stock, until such time
as our revenues are sufficient to meet our cost structure, and
ultimately achieve profitable operations. Management estimates that it
will need $1,000,000 over the next twelve months, and $3,000,000 to
fund all of the Company’s current product development and marketing
projects, including $1,000,000 to fund marketing programs for the Kidz-
Med Non-contact 5-in-1 thermometer. There is no assurance we will be
successful in raising additional capital or achieving profitable
operations. Furthermore, the large number of shares available from the
selling stockholder pursuant to the prospectus and the depressive
effect of the availability of such shares could make it difficult for
us to raise funds from other sources. Wherever possible, our board of
directors will attempt to use non-cash consideration to satisfy
obligations. In many instances, we believe that the non-cash
consideration will consist of restricted shares of our common stock.
These actions will result in dilution of the ownership interests of
existing stockholders and may further dilute common stock book value,
and that dilution may be material.